Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma.

MLA

Pierce, Angela M., et al. “Establishment of Patient-Derived Orthotopic Xenograft Model of 1q+ Posterior Fossa Group A Ependymoma.” Neuro-Oncology, vol. 21, no. 12, Dec. 2019, pp. 1540–51. EBSCOhost, https://doi.org/10.1093/neuonc/noz116.

APA

Pierce, A. M., Witt, D. A., Donson, A. M., Gilani, A., Sanford, B., Sill, M., Van Court, B., Oweida, A., Prince, E. W., Steiner, J., Danis, E., Dorris, K., Hankinson, T., Handler, M. H., Jones, K. L., Karam, S. D., Serkova, N. J., Vibhakar, R., Foreman, N. K., & Griesinger, A. M. (2019). Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma. Neuro-Oncology, 21(12), 1540–1551. https://doi.org/10.1093/neuonc/noz116

Chicago

Pierce, Angela M, Davis A Witt, Andrew M Donson, Ahmed Gilani, Bridget Sanford, Martin Sill, Benjamin Van Court, et al. 2019. “Establishment of Patient-Derived Orthotopic Xenograft Model of 1q+ Posterior Fossa Group A Ependymoma.” Neuro-Oncology 21 (12): 1540–51. doi:10.1093/neuonc/noz116.